secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cocrystal Pharma, Inc. (COCP)
CIK:        0001412486
Form:       8-K
Filed at:   2025-07-01T23:59:59+00:00
Accession:  0001641172-25-017370
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Cocrystal Pharma shareholders elect directors, ratify auditor, approve 2025 equity plan
--------------------------------------------------------------------------------

- Elected six directors: Kornberg (4,386,691 for), Frost (4,344,444 for), Hassan (4,440,602 for), Japour, Pfenniger, Rubin.
- Ratified Weinberg & Company as independent auditor for FY2025 (6,166,964 for, 452,222 against).
- Approved 2025 Equity Incentive Plan (3,764,418 for, 714,962 against).
- Adjournment proposal moot due to sufficient votes on other proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1412486/000164117225017370/0001641172-25-017370-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1412486/000164117225017370/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-017370

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer